RNA Synthesis: Phosphoramidites for RNA synthesis in the reverse direction. Highly efficient synthesis and application to convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′- end

Abstract Defined sequence RNA synthesis by 3′→5′ direction is now well established and currently in use for synthesis and development of vast variety of therapeutic grade RNA and Si RNA etc. A number of such synthetic RNA requires a modification or labeling of 3′- end of an oligonucleotide. The synt...

Full description

Saved in:
Bibliographic Details
Published inNucleic Acids Symposium Series Vol. 52; no. 1; pp. 103 - 104
Main Authors Srivastava, Suresh C., Pandey, Divya, Srivastava, Naveen P., Bajpai, Satya P.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Defined sequence RNA synthesis by 3′→5′ direction is now well established and currently in use for synthesis and development of vast variety of therapeutic grade RNA and Si RNA etc. A number of such synthetic RNA requires a modification or labeling of 3′- end of an oligonucleotide. The synthesis of 3′- end modified RNA requiring lipophilic, long chain ligands or chromophores, using 3′ → 5′ synthesis methodology is challenging, requires corresponding solid support and generally results in low coupling efficiency and lower purity of the final oligonucleotide in general because of large amount of truncated sequences containing desired hydrophobic modification. We have approached this problem by developing reverse RNA monomer phosphoramidites for RNA synthesis in 5′ → 3′- direction. They lead to very clean oligonucleotide synthesis allowing for introduction of various modifications at the 3′- end.
AbstractList Abstract Defined sequence RNA synthesis by 3′→5′ direction is now well established and currently in use for synthesis and development of vast variety of therapeutic grade RNA and Si RNA etc. A number of such synthetic RNA requires a modification or labeling of 3′- end of an oligonucleotide. The synthesis of 3′- end modified RNA requiring lipophilic, long chain ligands or chromophores, using 3′ → 5′ synthesis methodology is challenging, requires corresponding solid support and generally results in low coupling efficiency and lower purity of the final oligonucleotide in general because of large amount of truncated sequences containing desired hydrophobic modification. We have approached this problem by developing reverse RNA monomer phosphoramidites for RNA synthesis in 5′ → 3′- direction. They lead to very clean oligonucleotide synthesis allowing for introduction of various modifications at the 3′- end.
Defined sequence RNA synthesis by 3'-->5' direction is now well established and currently in use for synthesis and development of vast variety of therapeutic grade RNA and Si RNA etc. A number of such synthetic RNA requires a modification or labeling of 3'- end of an oligonucleotide. The synthesis of 3'- end modified RNA requiring lipophilic, long chain ligands or chromophores, using 3' --> 5' synthesis methodology is challenging, requires corresponding solid support and generally results in low coupling efficiency and lower purity of the final oligonucleotide in general because of large amount of truncated sequences containing desired hydrophobic modification. We have approached this problem by developing reverse RNA monomer phosphoramidites for RNA synthesis in 5' --> 3'- direction. They lead to very clean oligonucleotide synthesis allowing for introduction of various modifications at the 3'- end.
Defined sequence RNA synthesis by 3'-->5' direction is now well established and currently in use for synthesis and development of vast variety of therapeutic grade RNA and Si RNA etc. A number of such synthetic RNA requires a modification or labeling of 3'- end of an oligonucleotide. The synthesis of 3'- end modified RNA requiring lipophilic, long chain ligands or chromophores, using 3' --> 5' synthesis methodology is challenging, requires corresponding solid support and generally results in low coupling efficiency and lower purity of the final oligonucleotide in general because of large amount of truncated sequences containing desired hydrophobic modification. We have approached this problem by developing reverse RNA monomer phosphoramidites for RNA synthesis in 5' --> 3'- direction. They lead to very clean oligonucleotide synthesis allowing for introduction of various modifications at the 3'- end.
Author Srivastava, Naveen P.
Pandey, Divya
Srivastava, Suresh C.
Bajpai, Satya P.
Author_xml – sequence: 1
  givenname: Suresh C.
  surname: Srivastava
  fullname: Srivastava, Suresh C.
  email: ssrivastava@chemgenes.com
  organization: ChemGenes Corp. 33 Industrial Way, Wilmington, MA 01887
– sequence: 2
  givenname: Divya
  surname: Pandey
  fullname: Pandey, Divya
  organization: ChemGenes Corp. 33 Industrial Way, Wilmington, MA 01887
– sequence: 3
  givenname: Naveen P.
  surname: Srivastava
  fullname: Srivastava, Naveen P.
  email: ssrivastava@chemgenes.com
  organization: ChemGenes Corp. 33 Industrial Way, Wilmington, MA 01887
– sequence: 4
  givenname: Satya P.
  surname: Bajpai
  fullname: Bajpai, Satya P.
  organization: ChemGenes Corp. 33 Industrial Way, Wilmington, MA 01887
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18776274$$D View this record in MEDLINE/PubMed
BookMark eNp9kT1v1TAUhi1URG9LJ3bkCQZI66_ECVtVAUWqAPExR772cWOU2MF2Kt2N39QfxMAvIbm5CCa82MNzHr867wk68sEDQk8oOaek4RdepXThoyclf4A2VIqqqJlkR2hDWEULTqvqGJ2l9I3MRxAiG_kIHdNayopJsUE_P72_xJ93PneQXHqFP3YhjV2IanDGZUjYhogXJv1hsPN4fuEIdxATYOMi6OyCP8fX7rbrdxisddqBz_8MKW-wGsfeabWwOAesg78Dv-eczzGYaa_BweLe3c4D6SXWXQxDWALB6hiCcfYgSQu6fpGd3qdUeZ-N__pxX2Dw5jF6aFWf4Oxwn6Kvb15_uboubj68fXd1eVNoJimf1yRrSoRkjKstKevaKiNkbaXmJWNKMNvQWpSNqkoqy4bRcltrRStBDDWGAj9Fz1fvGMP3CVJuB5c09L3yEKbUSs6rSgpGZvLFSuoYUopg2zG6QcVdS0m7VNoulbZrpTP99OCdtgOYv-yhwBl4tgJhGv9r-g2otLF_
CitedBy_id crossref_primary_10_1002_cpnc_84
crossref_primary_10_3390_molecules25153344
crossref_primary_10_1016_j_tetlet_2019_01_006
crossref_primary_10_1039_c2cc33477a
crossref_primary_10_1002_0471142700_nc0320s45
ContentType Journal Article
Copyright 2008 Oxford University Press 2008
Copyright_xml – notice: 2008 Oxford University Press 2008
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1093/nass/nrn053
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate Joint Symposium of the 18th International Roundtable on Nucleosides, Nucleotides and Nucleic Acids and the 35th International Symposium on Nucleic Acids Chemistry
EISSN 1746-8272
EndPage 104
ExternalDocumentID 10_1093_nass_nrn053
18776274
10.1093/nass/nrn053
Genre Journal Article
GroupedDBID -~X
0R~
123
18M
2WC
4.4
5RE
70E
AAMVS
AAOGV
AAPXW
AAVAP
ABPTD
ABQLI
ABXVV
ACGFS
ADHZD
AENZO
AFULF
ALMA_UNASSIGNED_HOLDINGS
ALUQC
BAYMD
C1A
CIDKT
CS3
DIK
D~K
E3Z
EJD
F5P
GX1
H13
HH5
IH2
KQ8
KSI
OAWHX
OJQWA
OK1
PEELM
RD5
ROX
RXO
TOX
TR2
WG7
X7H
ZKX
~91
---
53G
5VS
CGR
CUY
CVF
EBS
ECM
EIF
NPM
WOQ
~S-
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c2713-31781047223ab0588fad478f7c3522a42f918459a651759215b8ca1640d1dd1e3
IEDL.DBID TOX
ISSN 0261-3166
IngestDate Thu Apr 11 18:27:30 EDT 2024
Fri Aug 23 01:56:34 EDT 2024
Thu Nov 24 22:03:01 EST 2022
Wed Aug 28 03:19:08 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2713-31781047223ab0588fad478f7c3522a42f918459a651759215b8ca1640d1dd1e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/nass/article-pdf/52/1/103/3863354/nrn053.pdf
PMID 18776274
PQID 733667420
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_733667420
crossref_primary_10_1093_nass_nrn053
pubmed_primary_18776274
oup_primary_10_1093_nass_nrn053
PublicationCentury 2000
PublicationDate 2008-00-00
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – year: 2008
  text: 2008-00-00
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Nucleic Acids Symposium Series
PublicationTitleAlternate Nucleic Acids Symp Ser (Oxf)
PublicationYear 2008
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0000400797
ssj0036588
Score 1.7213356
Snippet Abstract Defined sequence RNA synthesis by 3′→5′ direction is now well established and currently in use for synthesis and development of vast variety of...
Defined sequence RNA synthesis by 3'-->5' direction is now well established and currently in use for synthesis and development of vast variety of therapeutic...
Defined sequence RNA synthesis by 3'-->5' direction is now well established and currently in use for synthesis and development of vast variety of...
SourceID proquest
crossref
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
StartPage 103
SubjectTerms Ligands
Oligoribonucleotides - chemical synthesis
Oligoribonucleotides - chemistry
Organophosphorus Compounds - chemistry
RNA - chemical synthesis
Title RNA Synthesis: Phosphoramidites for RNA synthesis in the reverse direction. Highly efficient synthesis and application to convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′- end
URI https://www.ncbi.nlm.nih.gov/pubmed/18776274
https://search.proquest.com/docview/733667420
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwELZQT1wQbYFuW9o5VJya7iZx4oTbClEVkIpUutLeIsd2aKRdp9qkh73xTDwQB56EGTu7_UPtzUomjpPP9nwzHo8ZO0qFTvIkU4FUJQ94WspAcizlOq-ESiVedtk-z9OzCf86TaZ9gGz7nyX8PB5aZJFDu7DYXXCqRYZC4-_y-3TtSqF-KPK1nRWjUs3WrpUwTftteQ_quqeI7m1ue8Qxna45fc1e9SQRxh7VTfbC2C22PbZoIM-X8AFc2Kbzh2-zPxfnY_ixtEjk2rr9iPea9voKgZ3XGulkC8hKgWTalQzUFrAElLxp0RrwWg3xOQGK-pgtwbi8EqiO7jwkrYY7q93QNeAj1p1cTQHv2meihaaCWf2T9hAfg7qieD9qkPF1zBtN0UneUUii_hX4pa6VsnNti__--h2AsfoNm5x-vvx0FvSHNgQqQoMXf7jIQpeCMpblCJGopOYiQ-CJ6kkeVTkalUku0wSZS46Mo8yURKNtpEOtQxO_ZRu2sWaHQcm1USJTlBmKK5kQla2QD1Y4b0RlGA_Y0QrB4trn5ij8mnpcENCFB3rADhHdpyVghXyBo4uWTKQ1zU1bULLIVPBoNGDvfI-4rScTgg4u2n22-j320keZkONmn210ixvzHqlMVx4gif_y7cB15382jvY-
link.rule.ids 315,786,790,1611,4043,27954,27955,27956
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=RNA+Synthesis%3A+phosphoramidites+for+RNA+synthesis+in+the+reverse+direction.+Highly+efficient+synthesis+and+application+to+convenient+introduction+of+ligands%2C+chromophores+and+modifications+of+synthetic+RNA+at+the+3%27-end&rft.jtitle=Nucleic+acids+symposium+series+%282004%29&rft.au=Srivastava%2C+Suresh+C&rft.au=Pandey%2C+Divya&rft.au=Srivastava%2C+Naveen+P&rft.au=Bajpai%2C+Satya+P&rft.date=2008&rft.eissn=1746-8272&rft.issue=52&rft.spage=103&rft_id=info:doi/10.1093%2Fnass%2Fnrn053&rft_id=info%3Apmid%2F18776274&rft.externalDocID=18776274
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0261-3166&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0261-3166&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0261-3166&client=summon